MedTrace Logo

Efficacy Analysis of Comparison of CAMS（Chinese Academy of Medical Sciences）-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia

NCT03165851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2026-02-11

No results posted yet for this study

Summary

The investigators adopted the CAMS（Chinese Academy of Medical Sciences）-2009 trial for pediatric acute myeloid leukemia (AML) patients between 2009 to 2015, in which a risk-stratified strategy and dose-dense intensive chemotherapy were introduced. The outcomes of CAMS-2009 trial were retrospectively analyzed, and compared to the CAMS-2005 trial.

Conditions

  • Acute Myeloid Leukemia, Pediatric

Interventions

OTHER

Risk-stratified therapy

Dose-dense intensive chemotherapy and high dose of Ara-C in the consolidation therapy.

Sponsors & Collaborators

  • Institute of Hematology & Blood Diseases Hospital, China

    lead OTHER

Principal Investigators

  • Zhu Xiaofan · Institute of Hematology & Blood Disease Hospital

Eligibility

Min Age
6 Months
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-10
Primary Completion
2012-12-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03165851 on ClinicalTrials.gov